Janux Therapeutics
A clinical-stage biopharmaceutical company developing novel immunotherapies.
About
Janux Therapeutics is a clinical-stage biopharmaceutical company developing precision-engineered immunotherapies. Their proprietary TRACTr, TRACIr, and ARM platforms are designed to selectively modulate T cells to fight cancer and autoimmune diseases, aiming to transform patients' lives. They are currently evaluating their lead tumor-activated T cell engager (TRACTr) in a clinical trial for prostate cancer. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does Janux Therapeutics do?
Janux Therapeutics is a Biotechnology company that offers Platform. Teams look it up for Pharmaceuticals, Healthcare, Immunotherapy. It is based in San Diego, California, USA and was founded in 2017. Public records show about 110 people and $181M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Janux Therapeutics raised?
Janux Therapeutics has raised a total of $181M in funding. The most recent round on record is Series B.
Where is Janux Therapeutics headquartered?
Janux Therapeutics is headquartered in San Diego, California, USA.
When was Janux Therapeutics founded?
Janux Therapeutics was founded in 2017.
What industry does Janux Therapeutics operate in?
Janux Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy, Biotech.
How many employees does Janux Therapeutics have?
Janux Therapeutics has approximately 110 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.